One – Third of Indian Cancer Patients are over 60

Aruni Ghose shared a post by HCG (CARE) Centre for Academic Research on LinkedIn, adding:

“My Mentor Vanita Noronha, the Indian Geriatric Oncology stalwart is revolutionising the Cancer care in older patients Continuum both in India and the LMIC landscape.

This is a must read from both Geries and Global Oncology perspective as well as Population Health – Nicolò Matteo, Luca Battisti, Ravindran Kanesvaran, Giuseppe Banna, Akash Maniam.

Not only do we see an ageing population but also a massive cohort way greater than many HICs combined – Assessments and Services need to be both COST and TIME Efficient.

Call for BIDIRECTIONAL relationships between HICs and LMICs.”

Quoting HCG (CARE) Centre for Academic Research’s post:

“GIST – a window to the world of Oncology

𝗖𝗮𝗻𝗰𝗲𝗿 𝗶𝗻 𝗔𝗴𝗶𝗻𝗴 𝗜𝗻𝗱𝗶𝗮: 𝗡𝗲𝘄 𝗦𝘁𝘂𝗱𝘆 𝗥𝗲𝘃𝗲𝗮𝗹𝘀 𝗧𝗿𝗲𝗻𝗱𝘀

A comprehensive study across 17 Indian institutions has uncovered important insights about cancer in older adults.

Published in Cancer Epidemiology, the research shows that 36% of cancer patients are over 60, with men more affected than women. Head and neck cancers lead at 19.6%, followed by breast, genitourinary, lung, and liver cancers.

This data is crucial for healthcare planning as India’s population ages, highlighting the need for specialized geriatric oncology care.

For medical professionals, it guides clinical practices and research focus. For the public, it underscores the importance of cancer awareness and screening for older adults.

As India faces an aging population, addressing cancer in seniors becomes a key public health priority. Read all about it here.”

Source: Aruni Ghose/LinkedIn and HCG (CARE) Centre for Academic Research/LinkedIn

Aruni Ghose, an Internal Medicine Resident at Barts Health NHS Trust, holds a council position in the Oncology Section at the Royal Society of Medicine. Additionally, he serves as a Focused Topic Network Member at the European Cancer Organisation and sits on the Editorial Board at BMC. His research focuses on Genitourinary Cancer, Immuno Oncology, Global Oncology, Cardio Oncology, and Lung Cancer.

Gevorg Tamamyan is the Editor-in-chief of OncoDaily, Head of the Pediatric Cancer and Blood Disorders Center of Armenia, Chairman and Professor of the Department of Hematology and Pediatric Oncology at Yerevan State Medical University, CEO of the Immune Oncology Research Institute, President-Elect of the Pediatric Oncology East and Mediterranean (POEM) Group, Chairman of the Board of the Institute of Cancer and Crisis.

Recently Dr. Tamamyan has been selected as the President-Elect for SIOP Asia 2024.